Skip to main content
Clinical Trials/NCT04145791
NCT04145791
Completed
N/A

Ice Application for Postoperative Pain: a Randomized Control Trial

University of Texas Southwestern Medical Center2 sites in 1 country74 target enrollmentFebruary 15, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Postoperative Pain
Sponsor
University of Texas Southwestern Medical Center
Enrollment
74
Locations
2
Primary Endpoint
Pain score of cryotherapy patients as compared to non-cryotherapy patients
Status
Completed
Last Updated
last year

Overview

Brief Summary

The purpose of the proposed study is to investigate the effectiveness of cryotherapy as an additional form of pain control in women undergoing laparoscopic hysterectomy for benign gynecologic conditions through a randomized trial.

Detailed Description

The purpose of the proposed study is to investigate the effectiveness of cryotherapy as an additional form of pain control in women undergoing laparoscopic hysterectomy for benign gynecologic conditions through a randomized trial. The following aims will be pursued: Primary Aim: To determine if cryotherapy patients will have lower pain scores on VAS compared to standard pain management patients. Primary Hypothesis: Patients receiving cryotherapy will have lower VAS scores compared to patients receiving pain management. Secondary Aim 1: To determine if cryotherapy will reduce the number of morphine milligram equivalent (MME) compared to patients with standard pain management. Secondary Hypothesis 1: Patients receiving cryotherapy will have lower MME values compared to patients with standard pain management. Secondary Aim 2: To determine if cryotherapy will result in earlier return to baseline activity as measured by Quality of Recovery Questionnaire (QoR). Secondary Hypothesis 2: Patients receiving cryotherapy will return to baseline activity level sooner than those receiving standard pain management. Secondary Aim 3: To determine if cryotherapy will result in a faster time to discharge as determined by duration between admission to postanesthesia care unit (PACU) and discharge home. Secondary Hypothesis 3: Patient receiving cryotherapy will be have a shorter stay in PACU.

Registry
clinicaltrials.gov
Start Date
February 15, 2019
End Date
February 3, 2021
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Kimberly Kho

Associate Professor of Medicine

University of Texas Southwestern Medical Center

Eligibility Criteria

Inclusion Criteria

  • Women undergoing laparoscopic hysterectomy for benign indications within 8 weeks of enrollment
  • Women \>18 years of age
  • Non-emergent surgery
  • Non-pregnant
  • Women undergoing laparoscopic hysterectomy with the minimally invasive surgery team

Exclusion Criteria

  • Requires surgery for urinary incontinence
  • Has acute angle glaucoma
  • Has severe cardiac/respiratory disease
  • Current chronic pain condition (ie chronic pelvic pain, fibromyalgia, chronic low back pain)
  • Chronic use/abuse of opioid medications for greater than 1 week preceding procedure
  • Chronic NSAID use
  • Current treatment of opioid dependence with methadone or buprenorphine
  • Non-English or Non-Spanish speaking
  • Procedure converted to laparotomy

Outcomes

Primary Outcomes

Pain score of cryotherapy patients as compared to non-cryotherapy patients

Time Frame: pain score collected at two weeks post operative.

To determine if cryotherapy patients will have lower pain scores on a visual analog scale (VAS) compared to standard pain management patients at the time of same day discharge. VAS requires that patients mark their level pain along a straight 100mm line. There are no number markings on the scale. The beginning of the line is labeled on the left as "no pain" and the end of the line on the right is labeled as "worst pain imaginable." Once marked by the patient, the distance from beginning of the line to the patient's hash mark is measured in millimeters and that value is recorded as the pain level. The minimum is 0 (no pain) and the maximum is 100 (worst pain imaginable).

Secondary Outcomes

  • Narcotic usage(postoperative day one)
  • Time to discharge(day of surgery, up to 1440 minutes)
  • Quality of Recovery (QoR)(through study completion to take place at preoperative visit, and post operative day #14.)

Study Sites (2)

Loading locations...

Similar Trials